Product Type
Condition
Binding
Collectible Attributes
Seller Location
Seller Rating
Published by Springer Berlin Heidelberg, 2010
ISBN 10: 3642092306ISBN 13: 9783642092305
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. With contributions by numerous experts|Bang up-to-date, providing a state-of-the-art treatise on antibody therapeuticsIncludes contributions from a wide variety of renowned experts in the fieldThis essential work, edited by two research.
Published by Springer Berlin Heidelberg Nov 2010, 2010
ISBN 10: 3642092306ISBN 13: 9783642092305
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This essential work, edited by two researchers at London's famous Queen Mary's medical school targets one of the most important areas in medical development today. These days, antibody therapeutics are the treatment of choice for several autoimmune and oncological conditions. They are, indeed, becoming the molecules of choice for further combination therapies and cell engineering. In this timely work, a slew of expert in the field of drug development summarize all the current developments and clinical successes. 392 pp. Englisch.
Published by Springer, 2010
ISBN 10: 3642092306ISBN 13: 9783642092305
Seller: Revaluation Books, Exeter, United Kingdom
Book
Paperback. Condition: Brand New. 392 pages. 9.00x6.00x0.93 inches. In Stock.
Published by Springer Berlin Heidelberg, 2010
ISBN 10: 3642092306ISBN 13: 9783642092305
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Antibody therapeutics are the treatment of choice for several autoimmune and oncological conditions and are becoming the molecules of choice for further combination therapies and cell engineering. Current developments and clinical successes are summarised by experts in the drug development field. A must read for immunologists, clinical scientists and novel drug developers.